Franklin US Rising Dividends F (USD) (TML5039)
63.34
+0.98 (+1.58%)
USD |
May 24 2022
Returns Chart
Key Stats
Customize
| Expense Ratio | Total Assets Under Management | Dividend Yield | Turnover Ratio |
|---|---|---|---|
| 1.40% | 988.31M | 0.45% | -- |
| 1 Year Fund Level Flows | 1 Year Total Returns (Daily) | Annualized All Time Total Returns (Daily) | Max Drawdown (All) |
| -20.30M | -1.61% | Upgrade | Upgrade |
Basic Info
| Investment Strategy | |
| Long-term capital appreciation by investing primarily in a diversified portfolio of American equities, with a focus on investing in companies that have paid consistently rising dividends. |
| General | |
| Security Type | Mutual Fund |
| Oldest Share Symbol | TML231 |
| Equity Style | Large Cap/Blend |
| Fixed Income Style | High Quality/Limited Sensitivity |
| Broad Asset Class | -- |
| Broad Category | Equity |
| Category Name | US Equity |
| Category Index | -- |
| Prospectus Objective | -- |
| Fund Owner Firm Name | Franklin Templeton Investments Corp |
| Prospectus Benchmark Index | |
| S&P 500 TR CAD | 100.0% |
| Broad Asset Class Benchmark Index | |
| ^SPTSX60TR | 100.0% |
| Manager Tenure | |
| Donald Taylor | 14.62 yrs |
| Nicholas Getaz | 6.33 yrs |
| Matthew Quinlan | 1.17 yrs |
Net Fund Flows Versus Category
1 Month
% Rank:
--
--
Category Low
--
Category High
1 Year
% Rank:
82
-20.30M
-571.71M
Category Low
2.838B
Category High
3 Months
% Rank:
--
--
Category Low
--
Category High
3 Years
% Rank:
--
--
Category Low
--
Category High
6 Months
% Rank:
--
--
Category Low
--
Category High
5 Years
% Rank:
--
--
Category Low
--
Category High
YTD
% Rank:
--
--
Category Low
--
Category High
10 Years
% Rank:
--
--
Category Low
--
Category High
As of May 31, 2020
Performance Versus Category
As of May 24, 2022. Returns for periods of 1 year and above are annualized.
Annual Total Returns Versus Peers
As of May 24, 2022.
Asset Allocation
Top 10 Holdings
| Name | % Weight | Price | % Change |
|---|---|---|---|
| Microsoft Corp | 8.45% | 259.20 | -0.16% |
| Roper Technologies Inc | 5.81% | 425.39 | -0.37% |
| Stryker Corp | 3.75% | 233.47 | 0.08% |
| Accenture PLC Class A | 3.72% | 276.59 | -0.97% |
| Linde PLC | 3.61% | 314.16 | -1.98% |
| Air Products & Chemicals Inc | 3.58% | 235.70 | -0.47% |
| Becton, Dickinson and Co | 3.35% | 250.23 | -2.80% |
| Analog Devices Inc | 3.11% | 159.88 | -1.22% |
| Texas Instruments Inc | 2.94% | 167.73 | -0.08% |
| West Pharmaceutical Services Inc | 2.90% | 297.59 | -1.04% |
Basic Info
| Investment Strategy | |
| Long-term capital appreciation by investing primarily in a diversified portfolio of American equities, with a focus on investing in companies that have paid consistently rising dividends. |
| General | |
| Security Type | Mutual Fund |
| Oldest Share Symbol | TML231 |
| Equity Style | Large Cap/Blend |
| Fixed Income Style | High Quality/Limited Sensitivity |
| Broad Asset Class | -- |
| Broad Category | Equity |
| Category Name | US Equity |
| Category Index | -- |
| Prospectus Objective | -- |
| Fund Owner Firm Name | Franklin Templeton Investments Corp |
| Prospectus Benchmark Index | |
| S&P 500 TR CAD | 100.0% |
| Broad Asset Class Benchmark Index | |
| ^SPTSX60TR | 100.0% |
| Manager Tenure | |
| Donald Taylor | 14.62 yrs |
| Nicholas Getaz | 6.33 yrs |
| Matthew Quinlan | 1.17 yrs |
Fundamentals
| General | |
| Distribution Yield | Upgrade |
| Dividend Yield TTM (5-24-22) | 0.45% |
| 30-Day SEC Yield | -- |
| 7-Day SEC Yield | -- |
| Number of Holdings | Upgrade |
| Stock | |
| Weighted Average PE Ratio | 25.74 |
| Weighted Average Price to Sales Ratio | Upgrade |
| Weighted Average Price to Book Ratio | Upgrade |
| Weighted Median ROE | Upgrade |
| Weighted Median ROA | Upgrade |
| Forecasted Dividend Yield | Upgrade |
| Forecasted PE Ratio | Upgrade |
| Forecasted Price to Sales Ratio | Upgrade |
| Forecasted Price to Book Ratio | Upgrade |
As of May 31, 2020
Growth Estimates
Fund Details
| Key Dates | |
| Inception Date | 10/31/2000 |
| Last Annual Report Date | 12/31/2019 |
| Last Prospectus Date | -- |
| Share Classes | |
| TML111 | Institutional |
| TML141 | -- |
| TML201 | Commission-based Advice |
| TML231 | Fee-based Advice |
| TML3056 | Commission-based Advice |
| TML3911 | Fee-based Advice |
| TML517 | -- |
| TML5556 | Commission-based Advice |
| TML5559 | -- |
| TML5562 | Commission-based Advice |
| TML5829 | Commission-based Advice |
| TML5832 | Fee-based Advice |
| TML5834 | Institutional |
| TML5841 | Commission-based Advice |
| Attributes | |
| Enhanced Index Fund | No |
| Index Fund | No |
| Inverse Fund | No |
| Leveraged Fund | No |
| Fund of Funds | No |
| Currency Hedged Fund | No |
| Synthetic Replication Fund | No |
| Has Dividend Investment Plan | No |
| Socially Responsible Fund | No |